How much does one month of ceritinib/ceritinib treatment cost?

Ceritinib/Ceritinib As a second-generationALK inhibitor, it has been widely used to treat ALK-positive non-small cell lung cancer (NSCLC) patients, especially in the case of crizotinib resistance or intolerance, which has important clinical value. When many patients receive targeted therapy, in addition to paying attention to the efficacy, they are also more concerned about the cost of treatment, especially when it is not fully covered by medical insurance in China or requires self-pay. So, how much does a month of ceritinib treatment cost?

The current domestically approved standard dose of ceritinib is 450 mg once a day. It is recommended to take it after meals to improve bioavailability. Based on this dosage, approximately 30 450mg pills are needed per month. Since the domestic mainstream drug specification is 150 mg per pill, you need to take 3 pills a day, totaling about 90 pills of 150 mg per month. According to the market price, the monthly treatment cost of domestically marketed original ceritinib is about RMB 10,000, which is a considerable financial burden for many families.

It is worth noting that in addition to domestic original drugs, there are also generic versions from overseas on the market, especially generic drugs from countries such as Laos. Since these countries implement different drug patent policies, they allow the legal production of generic drugs during the patent period, thereby effectively reducing costs. Taking the Lao version as an example, the common specification is 150mg*60 capsules, and a bottle sells for about 1,000 yuan. According to the daily dose of 450mg, 90 pills are needed in a month, and about 1.5 bottles need to be purchased. The overall cost is controlled at about 1,500 yuan. Compared with the price of original research, the economic burden is significantly reduced.

Although the price difference is obvious, from the perspective of drug ingredients, overseas generic drugs are basically the same as the original drugs in terms of active ingredients, bioavailability and therapeutic effects, and have been widely used clinically in many countries. However, when patients choose overseas versions, they must obtain them through formal channels to avoid purchasing uncertified generic drugs from unknown sources.

Reference materials:https://go.drugbank.com/drugs/DB09063